Cardiology Clinic, Karolinska University Hospital
Stockholm, 17176, Sweden
NCT Number: NCT01428947
The purpose of the study is to study if coronary angiography cause cognitive dysfunction.
Looking for future studies?
Notify Me35 year–90 year
All sexes
Observational
Stockholm, 17176, Sweden
We have previously shown, using transcranial doppler, that coronary angiography cause cerebral microembolism. Cerebral microemboli were more common using the radial than femoral approach. Previously, cerebral microembolism has been associated with new cerebral lesions on MRI. The clinical significance of these new lesions is not determined. The primary aim of this pilot study is to see if coronary angiography cause cognitive dysfunction determined by the MoCA-test. A secondary aim is to relate cognitive dysfunction to cerebral microembolism measured by transcranial doppler. A third aim is to study potential differences between the femoral and radial approaches.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Randomization to right radial or femoral approach
Other names: Coronary arteriography
Time frame: Baseline and two days
The Montreal Cognitive Assesment test will be performed before, 2 and 30 days after coronary angiography
Time frame: Baseline
Cerebral microembolism will be studied by transcraniell doppler at the time of angiography. Findings will be related to change in cognitive function between baseline and two days.
Karolinska Institutet
Other
Study of Cognitive Function Before and After Coronary Angiography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05397392
Cardiovascular Diseases, Coronary Disease
Nanjing, China
View Trial DetailsNCT03696446
Behavior, Cardiovascular Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT07662317
Aortic Diseases, Arterial Occlusive Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial Details